We live in exciting times, on an extra-ordinary continent and have a colourful collection of people with rich heritages and unique healthcare needs. It takes an intrinsic understanding of the southern African environment to meet their healthcare requirements in a comprehensive manner.
Biotech Laboratories (Pty) Ltd is a South African pharmaceutical company founded in 1990 that markets, sells and distributes generic and branded pharmaceuticals to both the private and public sectors in South Africa. It is also active in the export markets within the SADC region.
An important aspect of the South African pharmaceutical environment is the empowerment of previously disadvantaged individuals and Biotech Laboratories embraces this philosophy at all stakeholder levels. The shareholding of Mr Shad Mapetla as Non-Executive Chairman (formerly CEO), is testimony to our continued Broad Based Black Economic Empowerment (BBBEE) commitment.
The company’s major shareholder, JB Chemicals Pharmaceuticals Ltd, is one of India’s leading global pharmaceutical companies. JB Chemicals Pharmaceuticals Ltd. has R D capabilities and a number of manufacturing facilities complying to international regulated market standards. It markets a wide range of pharmaceutical formulations, herbal remedies, bulk drugs, intermediates and radio-diagnostics.
It is Biotech’s mission to supply products that respond to the strategic health needs of developing nations. The company markets medicines from numerous therapeutic categories including anti-infectives, tuberculostatics, anti-inflammatories and products that treat the diseases of the cardiovascular, central nervous and respiratory systems as well as the urinary and gastro-intestinal tract.
Biotech launched a large and companion animal health division in 2011 and has partnered with a leading global veterinary research and development company based in the United Kingdom, Norbrook Laboratories. This division services the entire southern Africa with quality products that cover all major therapeutic categories.